Correlation Between Monte Rosa and NuCana PLC
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and NuCana PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and NuCana PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and NuCana PLC, you can compare the effects of market volatilities on Monte Rosa and NuCana PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of NuCana PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and NuCana PLC.
Diversification Opportunities for Monte Rosa and NuCana PLC
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Monte and NuCana is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and NuCana PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NuCana PLC and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with NuCana PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NuCana PLC has no effect on the direction of Monte Rosa i.e., Monte Rosa and NuCana PLC go up and down completely randomly.
Pair Corralation between Monte Rosa and NuCana PLC
Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to under-perform the NuCana PLC. But the stock apears to be less risky and, when comparing its historical volatility, Monte Rosa Therapeutics is 1.02 times less risky than NuCana PLC. The stock trades about -0.2 of its potential returns per unit of risk. The NuCana PLC is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 126.00 in NuCana PLC on December 1, 2024 and sell it today you would lose (29.00) from holding NuCana PLC or give up 23.02% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Monte Rosa Therapeutics vs. NuCana PLC
Performance |
Timeline |
Monte Rosa Therapeutics |
NuCana PLC |
Monte Rosa and NuCana PLC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Monte Rosa and NuCana PLC
The main advantage of trading using opposite Monte Rosa and NuCana PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, NuCana PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NuCana PLC will offset losses from the drop in NuCana PLC's long position.Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
NuCana PLC vs. Zura Bio Limited | NuCana PLC vs. ZyVersa Therapeutics | NuCana PLC vs. Cidara Therapeutics | NuCana PLC vs. Silence Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |